INS and diabetes mellitus: These changes collectively indicate that insulin pump therapy led to meaningful improvements in glycemic outcomes by reducing HbA1c, increasing time in range, and minimizing both the frequency and severity of hypoglycemia, all of which contribute to safer and more effective diabetes management (Table 3, Figures 3-7).